These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33592143)
1. Probing Amyloid β Interactions with Synthetic Heparan Sulfate Oligosaccharides. Wang P; Zhao J; Hossaini Nasr S; Otieno SA; Zhang F; Qiang W; Linhardt RJ; Huang X ACS Chem Biol; 2021 Oct; 16(10):1894-1899. PubMed ID: 33592143 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease. Schwörer R; Zubkova OV; Turnbull JE; Tyler PC Chemistry; 2013 May; 19(21):6817-23. PubMed ID: 23553710 [TBL] [Abstract][Full Text] [Related]
4. Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex. Lindahl B; Westling C; Giménez-Gallego G; Lindahl U; Salmivirta M J Biol Chem; 1999 Oct; 274(43):30631-5. PubMed ID: 10521448 [TBL] [Abstract][Full Text] [Related]
5. Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate. Xu D; Arnold K; Liu J Curr Opin Struct Biol; 2018 Jun; 50():155-161. PubMed ID: 29684759 [TBL] [Abstract][Full Text] [Related]
7. Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products. Cheng F; Ruscher K; Fransson LÅ; Mani K Glycobiology; 2013 Dec; 23(12):1510-9. PubMed ID: 24026238 [TBL] [Abstract][Full Text] [Related]
8. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. Bame KJ; Danda J; Hassall A; Tumova S J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014 [TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells. O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in the synthesis of extensive libraries of heparan sulfate oligosaccharides for structure-activity relationship studies. Ramadan S; Mayieka M; Pohl NLB; Liu J; Hsieh-Wilson LC; Huang X Curr Opin Chem Biol; 2024 Jun; 80():102455. PubMed ID: 38636446 [TBL] [Abstract][Full Text] [Related]
11. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics. Lookene A; Chevreuil O; Ostergaard P; Olivecrona G Biochemistry; 1996 Sep; 35(37):12155-63. PubMed ID: 8810923 [TBL] [Abstract][Full Text] [Related]
12. Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides. Cai C; Dickinson DM; Li L; Masuko S; Suflita M; Schultz V; Nelson SD; Bhaskar U; Liu J; Linhardt RJ Org Lett; 2014 Apr; 16(8):2240-3. PubMed ID: 24697306 [TBL] [Abstract][Full Text] [Related]
13. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy. Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094 [TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism. Ozsan McMillan I; Li JP; Wang L Am J Physiol Cell Physiol; 2023 Apr; 324(4):C893-C909. PubMed ID: 36878848 [TBL] [Abstract][Full Text] [Related]
15. Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. Kreuger J; Matsumoto T; Vanwildemeersch M; Sasaki T; Timpl R; Claesson-Welsh L; Spillmann D; Lindahl U EMBO J; 2002 Dec; 21(23):6303-11. PubMed ID: 12456637 [TBL] [Abstract][Full Text] [Related]
16. Interaction of the Heparin-Binding Consensus Sequence of β-Amyloid Peptides with Heparin and Heparin-Derived Oligosaccharides. Nguyen K; Rabenstein DL J Phys Chem B; 2016 Mar; 120(9):2187-97. PubMed ID: 26872053 [TBL] [Abstract][Full Text] [Related]
17. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease. Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596 [TBL] [Abstract][Full Text] [Related]
18. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate. Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084 [TBL] [Abstract][Full Text] [Related]
19. Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation. Cheng F; Cappai R; Ciccotosto GD; Svensson G; Multhaup G; Fransson LÅ; Mani K J Biol Chem; 2011 Aug; 286(31):27559-72. PubMed ID: 21642435 [TBL] [Abstract][Full Text] [Related]
20. Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements. Zong C; Venot A; Li X; Lu W; Xiao W; Wilkes JL; Salanga CL; Handel TM; Wang L; Wolfert MA; Boons GJ J Am Chem Soc; 2017 Jul; 139(28):9534-9543. PubMed ID: 28651046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]